Interleukin-1 and host control of pulmonary histoplasmosis

Journal of Infectious Diseases

Volumn 194, Issue 6, 2006, Pages 855-864

  Deepe Jr , George S ^a   McGuinness, Michael ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; GENETIC TRANSCRIPTION; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HOST RESISTANCE; INFECTION CONTROL; INTERFERON PRODUCTION; KNOCKOUT MOUSE; LUNG; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SIGNAL TRANSDUCTION; SUPERINFECTION;

ANIMALS; ANTILYMPHOCYTE SERUM; CYTOKINES; HISTOPLASMA; HISTOPLASMOSIS; INTERLEUKIN-1; LUNG; LUNG DISEASES, FUNGAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE; RECEPTORS, INTERLEUKIN-1; SPLEEN; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 33748422804     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/506946     Document Type: Article

References (31)

1. Deepe GS Jr. Histoplasma capsulatum. In: Mandell GL, Bennet JE, Dolin R, eds. Principles and practices of infectious diseases. 6th ed. Vol. 2. Philadelphia: Elsevier Churchill Livingstone, 2004:3012-26.
2. + T cells in host defense against Histoplasma capsulatum. Infect Immun 1988; 56:1685-91.
3. Lin JS, Yang CW, Wang DW, Wu-Hsieh BA. Dendritic cells cross-present exogenous fungal antigens to stimulate a protective CD8 T cell response in infection by Histoplasma capsulatum. J Immunol 2005; 174:6282-91.
4. Zhou P, Seder RA. CD40 ligand is not essential tor induction of type 1 cytokine responses or protective immunity after primary or secondary infection with Histoplasma capsulatum. J Exp Med 1998; 187:1315-24.
5. Allendorfer R, Brunner GD, Deepe GS Jr. Complex requirements for nascent and memory immunity in pulmonary hisloplasmosis. J Immunol 1999; 162:7389-96.
6. Allendoerfer R, Deepe GS Jr. Blockade of endogenous TNF-α exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms. J Immunol 1998; 160:6072-82.
7. Allendoerfer R, Deepe GS Jr. Intrapulmonary response to Histoplasma capsulatum in gamma interferon knockout mice. Infect Immun 1997; 65:2564-9.
8. Deepe GS Jr, Gibbons R, Woodward E. Neutralization of endogenous granulocyte-macrophage colony-stimulating factor subverts the protective immune response to Hisloplasma capsulatum. J Immunol 1999; 163:4985-93.
9. Allendoerfer R, Biovin GP, Deepe GS Jr. Modulation of immune responses in murine pulmonary histoplasmosis. J Infect Dis 1997; 175:905-14.
10. Wu-Hsieh B, Zlotnik A, Howard DH. T-cell hybridoma-produced lymphokine that activates macrophages to suppress intracellular growth of Histoplasma capsulatum. Infect Immun 1984; 43:380-5.
11. Zhou P, Sieve MC, Bennett J, et al. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-γ. J Immunol 1995; 155:785-95.
12. Zhou P, Miller G, Seder RA. Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-α plays a critical role in maintaining secondary immunity in the absence of IFN-γ. J Immunol 1998; 160:1359-68.
13. Deepe GS Jr, Gibbons RS. Protective and memory immunity to Histoplasma capsulatum in the absence of 1L-10. J Immunol 2003; 171:5353-62.
14. Peng JK, Lin JS, Kung JT, Finkelman FD, Wu-Hsieh BA. The combined effect of IL-4 and IL-10 suppresses the generation of, but does not change the polarity of, type-1 T cells in Histoplasma infection. Int Immunol 2005; 17:193-205.
15. Dinarello CA. The biological properties of interleukin-1. Eur Cytokine Netw 1994; 5:517-31.
16. Dinarello CA. Interleukin-1. Cytokine Growth Factor Rev 1997; 8:253-65.
17. Dinarello CA. Blocking IL-1 in systemic inflammation. J Exp Med 2005; 201:1355-9.
18. Cain JA, Deepe GS Jr. Evolution of the primary immune response to Histoplasma capsulatum in murine lung. Infect Immun 1998; 66:1473-81.
19. Hogquist KA, Nett MA, Sheehan KC, Pendleton KD, Schreiber RD, Chaplin DD. Generation of monoclonal antibodies to murine IL-1 beta and demonstration of IL-1 in vivo. J Immunol 1991; 146:1534-40.
20. Lewthwaite IC, Coates AR, Tormay P, et al. Mycobacterium tuberculosis chaperonin 60.1 is a more potent cytokine stimulator than chaperonin 60.2 (Hsp 65) and contains a CD14-binding domain. Infect Immun 2001; 69:7349-55.
21. Watson SR, Schmitt SK, Hendricks DE, Bullock WE. Immunoregulation in disseminated murine histoplasmosis: disturbances in the production of interleukins 1 and 2. J Immunol 1985; 135:3487-93.
22. Juffermans NP, Florquin S, Camoglio L, et al. Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. J Infect Dis 2000; 182:902-8.
23. Satoskar AR, Okano M, Connaughton S, Raisanen-Sokolwski A, David JR, Labow M. Enhanced Th2-like responses in IL-1 type 1 receptor-deficient mice. Eur J Immunol 1998; 28:2066-74.
24. Havell EA, Moldawer LL, Helfgott D, Kilian PL, Sehgal PB. Type I IL-1 receptor blockade exacerbates murine listeriosis. J Immunol 1992; 148:1486-92.
25. Hultgren OH, Svensson L, Tarkowski A. Critical role of signaling through IL-1 receptor for development of arthritis and sepsis during Staphylococcus aureus infection. J Immunol 2002; 168:5207-12.
26. Ozaki Y, Ohashi T, Minami A, Nakamura S. Enhanced resistance of mice to bacterial infection induced by recombinant human interleukin-1a. Infect Immun 1987; 55:1436-40.
27. Wheat LJ, Connolly-Stringfield PA, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) 1990; 69:361-74.
28. Romani L, Mencacci A, Cenci E, et al. Neutrophil production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice. J Immunol 1997; 158:5349-56.
29. Allendoerfer R, Deepe GS Jr. Regulation of infection with Histoplasma capsulatum by TNFR1 and -2. J Immunol 2000; 165:2657-64.
30. Helmby H, Grencis RK. Interleukin 1 plays a major role in the development of Th2-mediated immunity. Eur J Immunol 2004; 34:3674-81.
31. Wu-Hsieh BA, Lee GS, Franco M, Hofman FM. Early activation of splenic macrophages by tumor necrosis factor alpha is important in determining the outcome of experimental histoplasmosis in mice. Infect Immun 1992; 60:4230-8.